Johnson & Johnson highlights commitment to transform treatment of retinal diseases at ARVO 2024
Johnson & Johnson spotlighted its EYE-RD Global Registry at the Association for Research in Vision and Ophthalmology (ARVO) 2024 Annual Meeting held in Seattle in May. The first-of-its-kind observational, non-interventional global IRD...